Bulletin
Investor Alert

New York Markets Open in:

Zynex Inc.

NAS: ZYXI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Sep 17, 2020, 7:13 p.m.

/zigman2/quotes/205307175/composite

$

17.10

Change

-0.12 -0.70%

Volume

Volume 34,153

Quotes are delayed by 20 min

/zigman2/quotes/205307175/composite

Previous close

$ 16.01

$ 17.22

Change

+1.21 +7.56%

Day low

Day high

$15.70

$17.22

Open

52 week low

52 week high

$7.51

$29.73

Open

Company Description

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard ...

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Valuation

P/E Current

57.29

P/E Ratio (with extraordinary items)

50.45

P/E Ratio (without extraordinary items)

28.16

Price to Sales Ratio

5.88

Price to Book Ratio

13.07

Price to Cash Flow Ratio

42.41

Enterprise Value to EBITDA

21.39

Enterprise Value to Sales

5.67

Total Debt to Enterprise Value

0.02

Efficiency

Revenue/Employee

160,678.00

Income Per Employee

33,541.00

Receivables Turnover

10.55

Total Asset Turnover

2.05

Liquidity

Current Ratio

4.34

Quick Ratio

3.88

Cash Ratio

2.70

Profitability

Gross Margin

80.62

Operating Margin

24.34

Pretax Margin

26.26

Net Margin

20.87

Return on Assets

42.70

Return on Equity

65.17

Return on Total Capital

65.80

Return on Invested Capital

58.31

Capital Structure

Total Debt to Total Equity

23.72

Total Debt to Total Capital

19.17

Total Debt to Total Assets

16.56

Long-Term Debt to Equity

17.36

Long-Term Debt to Total Capital

14.03

Officers and Executives

Name Age Officer Since Title
Mr. Thomas Sandgaard 60 1996 Chairman, President & Chief Executive Officer
Mr. Giuseppe Papandrea 46 2019 Chief Operating Officer
Mr. Daniel J. Moorhead 46 2017 Chief Financial Officer
Ms. Chelle van Burkleo - - Vice President-Sales
Mr. Barry D. Michaels 69 2018 Independent Director

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
09/08/2020 Daniel J. Moorhead
Chief Financial Officer
800   Derivative/Non-derivative trans. at $15.76 per share. 12,608
09/05/2020 Daniel J. Moorhead
Chief Financial Officer
5,000   Award at $0 per share. 0
08/05/2020 Daniel J. Moorhead
Chief Financial Officer
3,376   Award at $0 per share. 0
08/05/2020 Giuseppe Papandrea
Chief Operating Officer
3,125   Award at $0 per share. 0
08/04/2020 Daniel J. Moorhead
Chief Financial Officer
161   Derivative/Non-derivative trans. at $18.05 per share. 2,906
07/30/2020 Daniel J. Moorhead
Chief Financial Officer
2,733   Acquisition at $18.11 per share. 49,494
07/29/2020 Joshua R. Disbrow
Director
10,000   Award at $0 per share. 0
07/29/2020 Joshua R. Disbrow
Director
10,000   Award at $0 per share. 0
07/29/2020 Barry D. Michaels
Director
10,000   Award at $0 per share. 0
07/29/2020 Barry D. Michaels
Director
10,000   Award at $0 per share. 0
07/29/2020 Michael D. Cress
Director
10,000   Award at $0 per share. 0
07/29/2020 Michael D. Cress
Director
10,000   Award at $0 per share. 0
07/22/2020 Giuseppe Papandrea
Chief Operating Officer
2,399   Derivative/Non-derivative trans. at $21.43 per share. 51,410
07/22/2020 Giuseppe Papandrea
Chief Operating Officer
5,000   Award at $0 per share. 0
07/14/2020 Thomas Sandgaard
President, CEO and Chairman; Director
1,250,000   Disposition at $22 per share. 27,500,000
07/08/2020 Daniel J. Moorhead
Chief Financial Officer
1,000   Derivative/Non-derivative trans. at $21.43 per share. 21,430
06/05/2020 Daniel J. Moorhead
Chief Financial Officer
1,482   Derivative/Non-derivative trans. at $21.43 per share. 31,759
06/05/2020 Daniel J. Moorhead
Chief Financial Officer
5,000   Award at $0 per share. 0
/news/latest/company/us/zyxi

MarketWatch News on ZYXI

  1. Zynex upgraded to buy from neutral at B. Riley FBR

    8:43 a.m. July 29, 2020

    - Tomi Kilgore

  2. Zynex downgraded to neutral from buy at B.Riley FBR

    8:34 a.m. July 13, 2020

    - Tomi Kilgore

  3. These 4 stocks have strong technical momentum

    11:15 a.m. Aug. 16, 2019

    - Harry Boxer

/news/nonmarketwatch/company/us/zyxi

Other News on ZYXI

  1. AMD, SHOP among premarket gainers

    8:20 a.m. July 29, 2020

    - Seeking Alpha

  2. Zynex (ZYXI) Investor Presentation - Slideshow

    6:11 p.m. July 28, 2020

    - Seeking Alpha

  3. 10-Q: ZYNEX INC

    5:30 p.m. July 28, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. Zynex (ZYXI) to Report Q2 Earnings: What's in the Cards?

    11:10 a.m. July 27, 2020

    - Zacks.com

  5. ZYXI, IMV among premarket losers

    8:12 a.m. July 15, 2020

    - Seeking Alpha

  6. Zynex prices equity offering at $22

    4:11 a.m. July 15, 2020

    - Seeking Alpha

  7. Zynex Q2 orders grow 37%; raises Q2 and FY20 revenue guidance

    10:09 a.m. July 9, 2020

    - Seeking Alpha

  8. Zynex Q2 orders grow 37%; raises revenue guidance

    10:09 a.m. July 9, 2020

    - Seeking Alpha

  9. 7 A-Rated Growth Stocks That Are Loaded With Long-Term Potential

    3:19 p.m. June 18, 2020

    - InvestorPlace.com

  10. Zynex +9.1% on move into SmallCap 600

    5:37 p.m. June 10, 2020

    - Seeking Alpha

  11. How I Find The Right Start-Up To Invest In

    7:15 a.m. May 28, 2020

    - Seeking Alpha

  12. Screening For The Best Growth Stocks

    10:22 a.m. May 22, 2020

    - Seeking Alpha

  13. Loading more headlines...

At a Glance

Zynex, Inc.

9555 Maroon Circle

Englewood, Colorado 80112

Phone

1 8669407030

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$45.47M

Net Income

$9.49M

2019 Sales Growth

42.5%

Employees

283.00

/news/pressrelease/company/us/zyxi

Press Releases on ZYXI

  1. Zynex Reaches 400 Salesperson Milestone Ahead of Schedule

    9:00 a.m. Sept. 10, 2020

    - PR Newswire - PRF

  2. Zynex Reports 83% Order Growth for July and August

    2:13 p.m. Sept. 3, 2020

    - PR Newswire - PRF

  3. Zynex Announces Second Quarter 2020 Earnings

    4:01 p.m. July 28, 2020

    - PR Newswire - PRF

  4. Loading more headlines...
Link to MarketWatch's Slice.